JENNIFER A. DOUDNA, PH.D.

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

3 mention(s) identify JENNIFER A. DOUDNA, PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
JOHNSON & JOHNSON 2019-03-13 Professor of Chemistry; Professor of Biochemistry and Molecular Biology; Li Ka Shing Chancellor's Professor in Biomedical and Health; University of California, Berkeley Dr. Doudna is a pioneer in biochemistry and co-discovered CRISPR-Cas9, indicating a strong background in scientific research and technology, which may involve programming skills.
JOHNSON & JOHNSON 2020-03-11 Professor of Chemistry; Professor of Biochemistry & Molecular Biology; Li Ka Shing Chancellor's Professor in Biomedical and Health, University of California, Berkeley Dr. Doudna is a pioneer in biochemistry and co-discovered CRISPR-Cas9, a genome editing technology, indicating a strong technical background in scientific research and innovation, which may involve programming skills.
JOHNSON & JOHNSON 2021-03-10 Pioneer in the field of biochemistry, having co-discovered the simplified genome editing technique CRISPR-Cas9. Dr. Doudna is a pioneer in biochemistry and co-discovered CRISPR technology, indicating a strong background in scientific research and technical skills related to programming in genetic engineering.

JOHNSON & JOHNSON

Filing Date Source Excerpt
2019-03-13 Professor of Chemistry; Professor of Biochemistry and Molecular Biology; Li Ka Shing Chancellor's Professor in Biomedical and Health; University of California, Berkeley
2020-03-11 Professor of Chemistry; Professor of Biochemistry & Molecular Biology; Li Ka Shing Chancellor's Professor in Biomedical and Health, University of California, Berkeley
2021-03-10 Pioneer in the field of biochemistry, having co-discovered the simplified genome editing technique CRISPR-Cas9.

Data sourced from SEC filings. Last updated: 2025-07-01